Jonay P.
- Country
- Spain
- Department
- Nefrología
Research Overview
- Efficacy and Safety of Finerenone in Non-Diabetic Chronic Kidney Disease: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study
- Evaluation of Sodium Zirconium Cyclosilicate Efficacy in Managing Hyperkalemia in Chronic Kidney Disease Patients: A Phase III Randomized Clinical Trial
- Efficacy and Safety of Baxdrostat and Dapagliflozin on Renal and Cardiovascular Outcomes in Chronic Kidney Disease with Hypertension
Data & Insights
Has run more than one trial at 25 of 244 partner sites.
Specializations
Chronic Kidney Disease Management
This investigator specializes in treating non-diabetic chronic kidney disease and evaluating innovative therapeutic approaches to delay disease progression.
- Standard of Care Enhancement
- Disease Progression Prevention
- Renal Function Preservation
Their research extends to examining novel therapeutic agents in combination with established treatments.
Cardiorenal Medicine
The investigator focuses on the intersection of kidney disease and cardiovascular health, with particular attention to patients with concurrent hypertension.
- Blood Pressure Management
- Cardiovascular Risk Reduction
- Renal Function Monitoring
Their work encompasses evaluation of combination therapies for complex cardiorenal conditions.
Electrolyte Disorders
The investigator specializes in managing hyperkalemia in the context of chronic kidney disease, exploring various therapeutic interventions.
- Potassium Level Management
- Treatment Optimization
- Medication Safety Assessment
Their research includes evaluating novel treatments for electrolyte imbalances in renal patients.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.